English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Wednesday, April 22, 2026
Hengrui Pharma Reports Q1 2026 Results with Revenue and Net Profit Growth
恒瑞醫藥2026年一季度業績穩健增長 創新成果持續落地
Wednesday, March 25, 2026
Hengrui Pharma Announces Strong 2025 Annual Results
營收淨利再創新高!恒瑞醫藥2025年營收316.29億元 同比增長13.02% 淨利77.11億元 同比增長21.69%
Wednesday, May 28, 2025
Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair Wrap Up Successfully
Saturday, November 9, 2019
Novaliq and Jiangsu Hengrui Medicine Announce a Collaboration for Investigational NOV03 and CyclASol in China

Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575